Furthermore, TGM2 can modulate EMT through activation of the NF-κB pathway [46], and PTK2B is also involved in regulating EMT in HNSCC (including OSCC) [47]. The gene discussed is TGM2; the disease is head and neck squamous cell carcinoma.